Comparing Reyvow vs Ubrelvy
Reyvow | Ubrelvy |
|
---|
Reyvow (lasmiditan) | Ubrelvy (ubrogepant) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Migraine. Reyvow may also be used for purposes not listed in this medication guide. |
Prescription only
Ubrelvy may be used to treat acute migraine attacks in adults and works by blocking the effects of a protein, called CGRP that is thought to play a role in migraine attacks by causing pain, dilation... View more |
Related suggestions Migraine
|
|||||||||||||||
More about Reyvow (lasmiditan) | More about Ubrelvy (ubrogepant) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Reyvow has an average rating of 4.4 out of 10 from a total of 22 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 57% reported a negative effect. |
Ubrelvy has an average rating of 6.1 out of 10 from a total of 237 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 39% reported a negative effect. |
||||||||||||||||
Drug Class | |||||||||||||||||
Side Effects | |||||||||||||||||
See also: Reyvow side effects in more detail. |
See also: Ubrelvy side effects in more detail. |
||||||||||||||||
Generic Availability | |||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Reyvow prices |
View all Ubrelvy prices |
||||||||||||||||
Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
5.7 hours |
7 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | |||||||||||||||||
Some potential for abuse
Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 448 drugs are known to interact with Reyvow:
|
A total of 218 drugs are known to interact with Ubrelvy:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
October 11, 2019 |
December 23, 2019 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.